Arrowhead Pharmaceuticals (ARWR) Insider Trading & Ownership $15.13 -0.26 (-1.69%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$15.32 +0.18 (+1.22%) As of 05/23/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$7.23 M Get ARWR Insider Trade Alerts Want to know when executives and insiders are buying or selling Arrowhead Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARWR Insider Buying and Selling by Quarter Arrowhead Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/11/2025Christopher Richard AnzaloneCEOSell50,800$11.49$583,692.00 4/9/2025Christopher Richard AnzaloneCEOSell40,322$10.07$406,042.54 3/13/2025Christopher Richard AnzaloneCEOSell51,425$15.07$774,974.75 3/4/2025Christopher Richard AnzaloneCEOSell133,333$17.02$2,269,327.66 1/23/2025Adeoye Y OlukotunDirectorSell959$21.00$20,139.00 1/6/2025James C HamiltonInsiderSell32,729$19.82$648,688.78 1/6/2025Kenneth Allen MyszkowskiCFOSell27,167$19.83$538,721.61 1/6/2025Patrick O'brienCOOSell29,184$19.82$578,426.88 1/2/2025Christopher Richard AnzaloneCEOSell11,520$19.05$219,456.00 12/27/2024Adeoye Y OlukotunDirectorSell2,850$20.00$57,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/23/2024Christopher Richard AnzaloneCEOSell12,563$19.59$246,109.17 12/18/2024Christopher Richard AnzaloneCEOSell26,712$21.24$567,362.88 12/16/2024William D WaddillDirectorSell3,748$21.90$82,081.20 7/2/2024Tracie OliverInsiderSell9,394$25.28$237,480.32 (Data available from 1/1/2013 forward) ARWR Insider Trading Activity - Frequently Asked Questions Who is on Arrowhead Pharmaceuticals's Insider Roster? The list of insiders at Arrowhead Pharmaceuticals includes Adeoye Y Olukotun, Christopher Richard Anzalone, Douglas B Given, Hongbo Lu, James C Hamilton, Kenneth Allen Myszkowski, Martin Javier San, Patrick O'brien, Tracie Oliver, Victoria Vakiener, and William D Waddill. Learn more on insiders at ARWR. What percentage of Arrowhead Pharmaceuticals stock is owned by insiders? 4.30% of Arrowhead Pharmaceuticals stock is owned by insiders. Learn more on ARWR's insider holdings. Which Arrowhead Pharmaceuticals insiders have been buying company stock? The following insider purchased ARWR shares in the last 24 months: Hongbo Lu ($54,990.00). How much insider buying is happening at Arrowhead Pharmaceuticals? Insiders have purchased a total of 2,000 ARWR shares in the last 24 months for a total of $54,990.00 bought. Which Arrowhead Pharmaceuticals insiders have been selling company stock? The following insiders have sold ARWR shares in the last 24 months: Adeoye Y Olukotun ($77,139.00), Christopher Richard Anzalone ($9,791,442.75), Douglas B Given ($110,792.66), James C Hamilton ($2,381,773.12), Kenneth Allen Myszkowski ($3,057,309.69), Martin Javier San ($567,360.00), Patrick O'brien ($1,666,446.67), Tracie Oliver ($552,622.07), Victoria Vakiener ($82,746.19), and William D Waddill ($82,081.20). How much insider selling is happening at Arrowhead Pharmaceuticals? Insiders have sold a total of 781,212 Arrowhead Pharmaceuticals shares in the last 24 months for a total of $18,369,713.35 sold. Arrowhead Pharmaceuticals Key ExecutivesDr. Christopher R. Anzalone Ph.D. (Age 55)CEO, President & Director Compensation: $1.6MMr. Kenneth A. Myszkowski (Age 58)Chief Financial Officer Compensation: $834.34k1 recent tradesMr. Patrick O'Brien J.D. (Age 60)PharmD, COO, General Counsel & Secretary Compensation: $835.14kDr. James C. Hamilton M.D. (Age 46)MBA, Chief of Discovery & Translational Medicine Compensation: $762.14kDr. Mark M. Davis Ph.D.Founder and Founder & Director of Insert Therapeutics Inc & CalandoDr. Vincent Anzalone CFAHead of Investor Relations & VPMr. Howard LovyDirector of CommunicationsDr. Bruce D. Given M.D. (Age 70)Chief Medical Scientist Compensation: $486.31kDr. Mark Seefeld (Age 70)Head of Toxicology & VP Ms. Tracie Oliver (Age 62)Chief Commercial Officer Compensation: $449.58k More Insider Trading Tools from MarketBeat Related Companies Roivant Sciences Insider Selling Revolution Medicines Insider Selling Elanco Animal Health Insider Selling Blueprint Medicines Insider Selling BridgeBio Pharma Insider Selling Verona Pharma Insider Selling Grifols Insider Selling TG Therapeutics Insider Selling Axsome Therapeutics Insider Selling Lantheus Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NASDAQ:ARWR) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Hidden Energy Source Backed by Billionaires Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARWR Stock Free ARWR Stock Alerts